Search

everythinglearnresearchcommunity

for

Search:↓

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Leflunomide is more likely to help treat alopecia areata than cause it.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

New technologies help better understand and treat inflammatory skin diseases.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Finasteride helps female-pattern hair loss.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Psoriasis skin changes are complex and might need several biopsies for a clear diagnosis.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

HIV can cause unusual and severe skin problems that are hard to treat.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

A 10-year-old girl with Fox Fordyce disease improved with treatment, suggesting the disease can occur before puberty and might be underdiagnosed in young girls.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

A dog in Colorado was diagnosed with leishmaniasis, suggesting the disease might be present in the state.

Women with early onset androgenetic alopecia have worse lipid profiles.